Platelet rich plasma & stem cell therapy are the new treatment modality in the field of dermatology. Platelet rich plasma is a simple, cost-effective as well as feasible treatment option that comes along with high patient satisfaction for hair loss and alopecia. In stem cell therapy, rather than removing a large number of hairs to transplant to the area of hair loss, a small skin sample from the hair follicles are harvested, for the treatment of hair loss.
MARKET DYNAMICS
The platelet rich plasma & stem cell alopecia treatment market is anticipated to grow in the forecast, owing to rising cases of alopecia as well as the demand for better therapies for hair loss treatment. In addition, the opportunities from developing economies is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of platelet rich plasma & stem cell alopecia treatment market with detailed market segmentation by treatment, end user and geography. The global platelet rich plasma & stem cell alopecia treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading platelet rich plasma & stem cell alopecia treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global platelet rich plasma & stem cell alopecia treatment market is segmented on the basis of treatment and end user. Based on treatment, the market is segmented as, stem cell therapy and platelet rich plasma therapies. The platelet rich plasma & stem cell alopecia treatment market is categorized based on end user such as, dermatology clinics, hospitals and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global platelet rich plasma & stem cell alopecia treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The platelet rich plasma & stem cell alopecia treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting platelet rich plasma & stem cell alopecia treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the platelet rich plasma & stem cell alopecia treatment market in these regions.

Have a question?

Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global platelet rich plasma & stem cell alopecia treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The platelet rich plasma & stem cell alopecia treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting platelet rich plasma & stem cell alopecia treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the platelet rich plasma & stem cell alopecia treatment market in these regions.
The reports cover key developments in the platelet rich plasma & stem cell alopecia treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from platelet rich plasma & stem cell alopecia treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for platelet rich plasma & stem cell alopecia treatment market in the global market. Below mentioned is the list of few companies engaged in the platelet rich plasma & stem cell alopecia treatment market.
The report also includes the profiles of key platelet rich plasma & stem cell alopecia treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Eclipse
- Glofinn Oy
- Histogen Inc.
- Kerastem
- NovaGenix
- Regen Lab
- RepliCel Life Sciences
- Other Companies
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Platelet Rich Plasma & Stem Cell Alopecia Treatment Market - By Treatment
1.3.2 Platelet Rich Plasma & Stem Cell Alopecia Treatment Market - By End User
1.3.3 Platelet Rich Plasma & Stem Cell Alopecia Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. STEM CELL THERAPY
7.3.1. Overview
7.3.2. Stem Cell Therapy Market Forecast and Analysis
7.3.3. Adipose Market
7.3.3.1. Overview
7.3.3.2. Adipose Market Forecast and Analysis
7.3.4. Bone Marrow Market
7.3.4.1. Overview
7.3.4.2. Bone Marrow Market Forecast and Analysis
7.4. PLATELET RICH PLASMA THERAPIES
7.4.1. Overview
7.4.2. Platelet Rich Plasma Therapies Market Forecast and Analysis
8. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. DERMATOLOGY CLINICS
8.3.1. Overview
8.3.2. Dermatology Clinics Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Overview
9.1.2 North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis
9.1.3 North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Treatment
9.1.4 North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By End User
9.1.5 North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.1.5.1.1 United States Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.1.5.1.2 United States Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.1.5.2 Canada Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.1.5.2.1 Canada Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.1.5.2.2 Canada Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.1.5.3 Mexico Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.1.5.3.1 Mexico Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.1.5.3.2 Mexico Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.2. EUROPE
9.2.1 Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Overview
9.2.2 Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis
9.2.3 Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Treatment
9.2.4 Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By End User
9.2.5 Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.2.5.1.1 Germany Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.2.5.1.2 Germany Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.2.5.2 France Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.2.5.2.1 France Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.2.5.2.2 France Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.2.5.3 Italy Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.2.5.3.1 Italy Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.2.5.3.2 Italy Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.2.5.4 Spain Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.2.5.4.1 Spain Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.2.5.4.2 Spain Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.2.5.5 United Kingdom Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.2.5.5.1 United Kingdom Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.2.5.5.2 United Kingdom Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Overview
9.3.2 Asia-Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Treatment
9.3.4 Asia-Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.3.5.1.1 Australia Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.3.5.1.2 Australia Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.3.5.2 China Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.3.5.2.1 China Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.3.5.2.2 China Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.3.5.3 India Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.3.5.3.1 India Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.3.5.3.2 India Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.3.5.4 Japan Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.3.5.4.1 Japan Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.3.5.4.2 Japan Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.3.5.5 South Korea Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.3.5.5.1 South Korea Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.3.5.5.2 South Korea Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Overview
9.4.2 Middle East and Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Treatment
9.4.4 Middle East and Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.4.5.1.1 South Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.4.5.1.2 South Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.4.5.2 Saudi Arabia Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.4.5.2.1 Saudi Arabia Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.4.5.2.2 Saudi Arabia Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.4.5.3 U.A.E Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.4.5.3.1 U.A.E Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.4.5.3.2 U.A.E Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Overview
9.5.2 South and Central America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis
9.5.3 South and Central America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Treatment
9.5.4 South and Central America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By End User
9.5.5 South and Central America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.5.5.1.1 Brazil Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.5.5.1.2 Brazil Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
9.5.5.2 Argentina Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
9.5.5.2.1 Argentina Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by Treatment
9.5.5.2.2 Argentina Platelet Rich Plasma & Stem Cell Alopecia Treatment Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PLATELET RICH PLASMA & STEM CELL ALOPECIA TREATMENT MARKET, KEY COMPANY PROFILES
11.1. ECLIPSE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLOFINN OY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. HISTOGEN INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. KERASTEM
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVAGENIX
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. REGEN LAB
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. REPLICEL LIFE SCIENCES
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. OTHER COMPANIES
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Eclipse
2. Glofinn Oy
3. Histogen Inc.
4. Kerastem
5. NovaGenix
6. Regen Lab
7. RepliCel Life Sciences
8. Other Companies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.